Q4 2016 Holdings
Filed 2017-02-14 | 35 holdings | $10.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.8M | 270,000 | 76.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.9M | 51,935 | 19.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $44.0K | 2,601,351 | 0.4% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $33.3K | 3,000,000 | 0.3% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $32.1K | 2,010,000 | 0.3% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $30.3K | 4,973,509 | 0.3% |
| Zogenix Inc | COM NEW | 98978L204 | $29.7K | 2,440,959 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $29.0K | 750,000 | 0.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $27.7K | 828,253 | 0.3% |
| Medicines CoPut | COM | 584688105 | $25.5K | 750,000 | 0.2% |
| Ignyta Inc | COM | 451731103 | $21.2K | 4,000,000 | 0.2% |
| Merrimack Pharmaceuticals Inc | COM | 590328100 | $20.4K | 5,000,000 | 0.2% |
| Avexis Inc | COM | 05366U100 | $19.7K | 413,179 | 0.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $19.7K | 385,683 | 0.2% |
| Therapeuticsmd Inc | COM | 88338N107 | $18.9K | 3,276,010 | 0.2% |
| Trevena Inc | COM | 89532E109 | $17.6K | 3,000,650 | 0.2% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $15.9K | 437,865 | 0.2% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $14.5K | 1,000,000 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $13.0K | 370,000 | 0.1% |
| Bovie Medical Corp | COM | 10211F100 | $11.0K | 3,055,000 | 0.1% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $9.2K | 1,500,000 | 0.1% |
| Connecture Inc | COM | 20786J106 | $6.9K | 4,127,232 | 0.1% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $5.6K | 1,537,873 | 0.1% |
| Biocryst Pharmaceuticals(BCRX)Put | COM | 09058V103 | $4.6K | 725,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $4.4K | 350,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.1K | 870,261 | 0.0% |
| Ocera Therapeutics Inc | COM | 67552A108 | $4.1K | 1,963,777 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.5K | 114,080 | 0.0% |
| Biocryst Pharmaceuticals(BCRX)Call | COM | 09058V103 | $3.2K | 500,000 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $2.5K | 2,293,675 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $2.2K | 1,108,593 | 0.0% |
| Catabasis Pharmaceuticals Inc | COM | 14875P107 | $2.0K | 556,537 | 0.0% |
| Aradigm Corp(ARDMEUR) | COM NO PAR VALUE | 038505400 | $1.3K | 791,870 | 0.0% |
| Streamline Health Solutions | COM | 86323X106 | $190 | 151,611 | 0.0% |
| Ophthotech CorpCall | COM | 683745103 | $34 | 7,100 | 0.0% |